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Abstract. Consumers are becoming more aware of the impact on their health of the food they 
eat. One of the possible ways to reduce the risk of cardiovascular disease is consuming more 
polyunsaturated fatty acids (PUFA), particularly n-3 fatty acids. This study was undertaken to 
determine whether omega-3 fatty acids have effects on the serum level of cholesterol and triglycerides 
and anatomopathologic changes. Twenty-one Guinea pigs (12 weeks old) were randomly assigned to 
and fed a normal, high fat (0.5 % cholesterol) without (CD) or with Omega-3 (COD) diet for 12 
weeks. The CD diet increased serum triglycerides, total and LDL cholesterol levels by 50.28%, 
50.51% and 40.98 % respectively. Adding Omega-3 (0.6 mg/kg) in diet reduced the serum level of 
total cholesterol (59mg/dl vs. 39 mg/dl), triglycerides (94 mg/dl vs. 41 mg/dl) and LDL-C (45 mg/dl 
vs. 31 mg/dl). The animals fed with CD diet developed fibrosis of myocardium and artery besides 
those fed with COD diet where it was a marked reduction in coronary degenerative lesions from 
myocardium. We conclude that in our experimental model, dietary n-3 PUFAs decrease the 
development of coronary artery diseases, through changes in serum levels and anatomopathologic 
aspects. 
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INTRODUCTION 
 
Reducing intake of saturated fat and dietary cholesterol and avoiding excess calories, 
remain the cornerstone of the dietary approach to decreasing risk of atherosclerotic vascular 
disease. During the past 20 years, however, there has been renewed interest in other dietary 
components that might favorably improve lipid profiles and reduce risk of coronary heart 
disease (CHD). (Stone, 1996). Dietary intake of n-3 polyunsaturated fatty acids (PUFA), 
mostly derived from fish or as pharmacological supplements, is associated epidemiologically 
with cardiovascular protection. Randomized intervention trials have shown that n-3 PUFA 
reduce mortality endpoints, specifically sudden death and fatal myocardial infarction. (Albert 
et al, 2002; Kris-Etherton et al, 2002) Many studies have reported a negative relation between 
intake of omega-3 fatty acids (FAs) and CVD incidence and/or mortality (Osler et al., 2003; 
Ervin et al., 2004; Psota et al., 2006). Omega-3 PUFAs generally exert their cardioprotective 
effects through changes in lipids and lipoproteins. In addition, Omega-3 FAs especially EPA 
and DHA contribute benefits through their antiarrhythmic, anti-inflammatory, antithrombotic 
effects. Moreover, EPA and DHA also improve vascular endothelial function and help lower 
blood pressure, platelet sensitivity (Wijendran and Hayes, 2004). 
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The aim of this study was therefore to prove from an anatomopathologic, histologic 
and biochemical point of view the supposed protective role of the Omega 3 fatty acids in the 
prevention of the cardiovascular diseases induced by a nutrition high in cholesterol, using 
experimental models, based on a controlled diet.   
 
MATERIALS AND METHODS 
 
Materials 
Concentrated fish oil was extracted from Omacor capsules (Pronova, Norway), 
cholesterol was obtained from sheep wool powder, ~95% (GC), (Sigma-Aldrich), and the 
standard chow for Guinea pigs was obtained from Pannonmill Takarmany Kft., Hungary. 
Animals and Diets 
Twenty-one Guinea pigs were used for this study, which were randomized to three 
different dietary regimens: a standard chow diet, a high fat (0.5 % cholesterol) diet (CD) and 
high fat (0.5 % cholesterol) with Omega-3 (0.6 mg/kg) diet (COD). Guinea pigs were chosen 
because they are excellent models to evaluate the mechanisms by which diet interventions and 
drug treatments alter plasma lipids and lipoprotein metabolism (Fernandez and Volek, 2006) 
Guinea pigs were housed five per cage, in a temperature-controlled environment with a 12-h 
light–dark cycle, and allowed free access to food and water. Body weight was recorded once a 
week. The animals were sacrificed after 12 weeks on the experimental diet. 
Serum determinations 
Fasting serum samples were obtained for cholesterol and triglyceride determinations at 
baseline and after 4, 8 and 12 weeks on the experimental diet. The blood was collected from 
the retro orbicular sinus in serum separator tubes, and centrifuged immediately. Serum was 
then stored at 0-4 °C until analysis. The samples were analyzed with Konelab 20i clinical 
chemistry analyzer.  
Anatomopathological aspects 
After 12 weeks on experimental diets, Guinea pigs were sacrificed. The heart, 
including the aortic root was removed and prepared for histological procedures. Olympus 
CX41 microscope with camera was used for microscopic exam. 
 
RESULTS AND DISCUSSION 
 
Serum determinations  
 In the case of the control group all values of the parameters analyzed were according 
to the standard limits characteristic to this specie and didn’t present any significant changes 
during the entire experiment. (tab.1.) Therefore, the diet with an optimal lipid concentration 
(the combined diet administrated to this group contained 2.39% fat) does not determine an 
overstepping of the superior limits in the biochemical parameters.  
 After 6 weeks, during which the guinea pigs were administrated a high fat diet with 
0.5% cholesterol, the values of the parameters studied in the case of the positive group raised 
as following: total cholesterol from 48mg/dl to 89 mg/dl, LDL cholesterol from 36 mg/dl to 
47 mg/dl, HDL cholesterol from 4 mg/dl to 9 mg/dl, and triglycerides from 88 mg/dl to 129 
mg/dl. Although their values have risen compared to the initial ones, HDL cholesterol and 
LDL cholesterol values are in between the normal limits. The total cholesterol and 
triglyceride values moderately overstep the standard limits. These results are in accordance 
with the other data from studies done in this field,  Lin et al. (1994), obtaining similar results. 
After 12 weeks, the values of the parameters studied are higher also from baseline as well as 
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from day 45. It can be noticed that the cholesterol and triglyceride values have doubled 
compared to the initial ones, and the HDL cholesterol value has overstepped the superior 
limit. It is known as a well fact that the successive administration of cholesterol over a long 
period is directly proportional to the raising of the biochemical values in time. Therefore, we 
can observe that at 6 weeks from the diet’s administration with an add of 0.5% cholesterol the 
values are slightly higher, at 12 weeks, these values have doubled compared to the initial 
ones. The atherogen dyslipidemia includes the triad: high triglyceride level, a lower HDL 
cholesterol value, and the increase of the LDL cholesterol level. The triglyceride value is a 
risk factor independent for cardiovascular diseases. The raising of this value can be due to an 
endothelial dysfunction. (Shekelle et al, 1989). 
In the case of the Omega-3 group it can be noticed that the administration of a diet 
with an add of 0.5% cholesterol at the same time with the diet supplement Omacor has led to 
a decrease in the majority of the parameters studied. At 6 weeks it can be seen the decrease in 
the total cholesterol value from 59 mg/dl at 56 mg/dl, LDL cholesterol from 45 mg/dl to 
39mg/dl, and triglycerides from 94 mg/dl to 73 mg/dl. The exception remains in the HDL 
value which remains constant. The parameters values from the 12th week are lower compared 
to the values obtained in the 6th week as well as baseline, exception making the HDL 
cholesterol which presents a growing from 11 mg/dl to 15 mg/dl. This fact is explained by the 
benefic action that the polyunsaturated fatty acids with long chain have in the organism: they 
enrich the lipid rapport from blood decreasing the total cholesterol, triglycerides and VLDL, 
and at the same time increasing the HDL (benefic cholesterol). It can be noticed that the 
unsaturated fatty acids with long chain Omega – 3 types, acts especially on the serum level of 
the triglycerides, their value reducing to half. This fact can be explained by the step by step 
accumulation of these acids in the organism.   
Tab.1.  
The values of the biochemical parameters 
 
Total cholesterol Tryglicerides Diet 
 
 
Baseline 6 weeks 12 weeks Baseline 6 weeks 12 weeks 
Standard diet 51 mg/dl 58 mg/dl 65 mg/dl 82 mg/dl 90 mg/dl 120 mg/dl 
CD diet 48 mg/dl 89 mg/dl 97 mg/dl 88 mg/dl 129 mg/dl 177 mg/dl 
COD diet 59 mg/dl 56 mg/dl 39 mg/dl 94 mg/dl 73 mg/dl 41 mg/dl 
 
LDL cholesterol HDL cholesterol Diet 
 
 
Baseline 6 weeks 12 weeks Baseline 6 weeks 12 weeks 
Standard diet 48 mg/dl 42 mg/dl 52 mg/dl 6 mg/dl 17 mg/dl 19 mg/dl 
CD diet 36 mg/dl 47 mg/dl 61 mg/dl 4 mg/dl 9 mg/dl 9 mg/dl 
COD diet 45 mg/dl 39 mg/dl 31 mg/dl 11 mg/dl 11 mg/dl 15 mg/dl 
* Values are given as mean, in mg/dl 
 
 
Anatomopathological lesions 
In the case of the histological slides made from the samples taken from the control 
group, it can be noticed the normal histological structure in the arterial level. Therefore, the 
intima’s endothelium is smooth, without any disconnections of the elastic limitant and 
without any modifications in the muscular layer (fig. 1).  
 285 
 
            Fig. 1. Normal histological structure of     
              an artery – control group, TCM, 400X 
 
The slides sampled from the positive group presented significant histological 
modifications. In the myocardium (fig. 3) it can be seen the forming of the subendocardic 
fibrous nodules (dark red arrow), the rapport between the muscular tissue and the conjunctive 
one is in favor of the second one. Also we can see the presence of the diffuse interfascicular 
edema. The fibromatous proliferation (orange arrow) can also be seen in muscular layer of 
artery and subendothelial (fig. 2). 
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Fig. 2. Artery, fibromatous proliferation TCM, 200X Fig. 3. Myocardium , subendocardic fibrous nodule, 
TCM, 200X 
 
 The histological slides made from the organs of the guinea pigs from Omega-3 group 
presented microscopic alterations in a less advanced stadium compared to the positive control 
lot. In figure 4 and 5 it can be seen the histological alterations in the myocardium, of a reduce 
intensity compared to the positive group, because of the protection given by the Omega- 3 
fatty acids. Therefore, it can be seen the intimae’s thickness, infiltrated by the fatty cells 
beneath the vascular endothelium (blue arrow) and edema in the muscular layer (red arrow). It 
can be seen the enlarged macrophages (fatty cells) aspect and the nucleus pushed toward the 
periphery.  
      
 
Fig. 4. Artery, edema in the muscular layer, TCM, 
400X 
Fig. 5. Artery, fatty cells, TCM, 400X  
 
CONCLUSIONS 
 
1. The cholesterol’s sanguine concentration grows in direct proportion to the period of 
the high fat diet’s administration. (0.5% cholesterol adding). 
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2. Dietary cholesterol in high percents determines the increase of the biochemical 
parameters involved in the cardiovascular pathogenesis, especially the total cholesterol 
(with 50.51%) and the triglycerides (with 50.28%). 
3. In what concerns the biochemical parameters, the Omega – 3 influences clearly in the 
most obvious way the level of the triglycerides and total cholesterol, in decreasing 
their levels with 56.38%, and respectively 33.33%. 
4. Omega-3 intervenes in the modification of the lipoprotein fraction values, increasing 
the HDL- cholesterol and decreasing the LDL- cholesterol 
5. The administration of 0.5% cholesterol in the diet on a long term determines 
morphologic alterations in the arteries expressed through fibromatous proliferation 
and interfibrilar edema.  
6. The arterial protection in the case of supplementation the diet high in cholesterol with 
Omega -3 is not totally assured, fact proved by the presence of fatty cells in the 
vascular endothelium.  
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